Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,144 public trials 2,036 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

Navigating the Clinical Research Process for Lymphoma

NCT06070246

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Not yet recruiting

Lymph Node Microenvironment Modifications in Patients With CLL Treated With Venetoclax-based Regimens

NCT04790045

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

Patient Perspectives in Mantle Cell Lymphoma Clinical Research

NCT06049472

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Not yet recruiting

Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research

NCT06049485

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Not yet recruiting

The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.

NCT05990985

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The First Bethune Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Not yet recruiting

Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of HLX51 in Patients With Solid Tumor or Lymphoma

NCT05788107

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Not specified

View Trial Details

Not yet recruiting

Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers

NCT05834426

Conditions: Cancer, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +13 more
Locations: Instituto Oncológico Nacional Dr. Juan Tanca Marengo Guayaquil, Guayas, Ecuador

View Trial Details

Not yet recruiting

Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM

NCT05909826

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma

NCT05814848

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients

NCT05899543

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions